Literature DB >> 35112321

Evaluation of the antifungal activity of α, β, and δ-damascone and inclusion complexes in β-cyclodextrin against Candida spp.

Maria Rayane Correia de Oliveira1,2, Maria Gabriely de Lima Silva2, Antonia Thassya Lucas Dos Santos3, Francisco Lucas Alves Batista2, Roger Henrique Sousa da Costa2, Anita Oliveira Brito Pereira Bezerra Martins2, Beatriz Gonçalves da Cruz4, Maria Flaviana Bezerra Morais-Braga3, Henrique Douglas Melo Coutinho5, Francisco Ernani Alves Magalhães6, Diniz Maciel de Sena Junior4, Alexandre Magno Rodrigues Teixeira4, Irwin Rose Alencar de Menezes7.   

Abstract

Due to the increase in fungal resistance to existing drugs, a need exists to search for new antifungals. This study aimed to evaluate the antifungal activity of α, β, and δ-damascone and inclusion complexes with β-cyclodextrin against different Candida spp. The inclusion complex of β-damascone was prepared by the co-evaporation method using three molar proportions (1:1; 2:1; 3:1 (βDA-βCD)) and analyzed using Fourier transform infrared spectroscopy (FTIR). Standard Candida albicans (CA INCQS 40,006), Candida krusei (CK INCQS 40,095), and Candida tropicalis (CT INCQS 40,042) strains were used to evaluate antifungal activity. The substances were tested individually or in association with fluconazole (FCZ). The IC50 and cell viability curve constructions were performed using the microdilution method. The minimum fungicidal concentration (MFC) was determined by the subculture method in a solid medium. The α, β, and δ-DA isolated or in combination with fluconazole (FCZ) showed significant antifungal activity. β-damascone showed effective complexation in the three molar proportions assayed; however, none of the inclusion complexes was demonstrated clinically significant effects against the fungal tested. Then, all compounds have shown promising antifungal activities; however, in vivo assays are necessary to have therapeutical application in the future.
© 2022. Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35112321     DOI: 10.1007/s12223-021-00945-2

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  6 in total

1.  Invasive Candidiasis.

Authors:  Bart Jan Kullberg; Maiken C Arendrup
Journal:  N Engl J Med       Date:  2016-02-25       Impact factor: 91.245

2.  Psidium guajava L. and Psidium brownianum Mart ex DC.: Chemical composition and anti - Candida effect in association with fluconazole.

Authors:  Maria Flaviana B Morais-Braga; Débora L Sales; Joara Nalyda P Carneiro; Antonio Júdson T Machado; Antonia Thassya L Dos Santos; Maria Audilene de Freitas; Gioconda Morais de A Bezerra Martins; Nadghia Figueiredo Leite; Yedda Maria L S de Matos; Saulo R Tintino; Djair S L Souza; Irwin R A Menezes; Jaime Ribeiro-Filho; José G M Costa; Henrique D M Coutinho
Journal:  Microb Pathog       Date:  2016-04-13       Impact factor: 3.738

3.  De novo antimicrobial peptides with low mammalian cell toxicity.

Authors:  M M Javadpour; M M Juban; W C Lo; S M Bishop; J B Alberty; S M Cowell; C L Becker; M L McLaughlin
Journal:  J Med Chem       Date:  1996-08-02       Impact factor: 7.446

4.  Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine.

Authors:  Henrique D M Coutinho; José G M Costa; Edeltrudes O Lima; Vivyanne S Falcão-Silva; José P Siqueira-Júnior
Journal:  Chemotherapy       Date:  2008-08-12       Impact factor: 2.544

5.  Ellagic Acid-Cyclodextrin Complexes for the Treatment of Oral Candidiasis.

Authors:  Aline da Graça Sampaio; Aline Vidal Lacerda Gontijo; Gabriela de Morais Gouvêa Lima; Maria Alcionéia Carvalho de Oliveira; Laura Soares Souto Lepesqueur; Cristiane Yumi Koga-Ito
Journal:  Molecules       Date:  2021-01-19       Impact factor: 4.411

6.  Preparation and Characterization of Nanoparticle β-Cyclodextrin:Geraniol Inclusion Complexes.

Authors:  Zahra Hadian; Majedeh Maleki; Khosro Abdi; Fatemeh Atyabi; Abdoreza Mohammadi; Ramin Khaksar
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.